Document Detail

Favourable outcomes in episodes of Pseudomonas bacteraemia when associated with tunnelled cuffed catheters (TCCs) in chronic haemodialysis patients.
MedLine Citation:
PMID:  16421157     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Pseudomonas is regarded as a particularly lethal bacterial isolate. High mortality rates have been reported in episodes of Pseudomonas sepsis when associated with visceral infections as seen in immunosuppressed, hospitalized patients. In comparison, lower mortality rates have been reported with catheter-associated Pseudomonas bacteraemia in non-dialysis patients. The purpose of this study was to determine the risk factors and the outcomes for episodes of Pseudomonas bacteraemia associated with the use of tunnelled cuffed haemodialysis catheters (TCCs) in a chronic out-patient population. METHODS: We performed a prospective observational study in seven chronic haemodialysis units over a 2.5 year period. Patients who were diagnosed as having their initial TCC-associated bacteraemia within the study period were followed for 3 months. All episodes of Pseudomonas TCC bacteraemia were identified, and univariate analyses were performed to compare Pseudomonas bacteraemia with non-Pseudomonas bacteraemia. RESULTS: During the study period, 219 episodes of TCC bacteraemia were identified; 18 had a Pseudomonas isolate (8%). Pseudomonas bacteraemia episodes were associated with a significantly higher risk of not receiving appropriate initial antibiotics (odds ratio = 3.6, P = 0.02). There were no deaths in the Pseudomonas bacteraemia group, whereas 19% died in the non-Pseudomonas group. The TCC was removed in 89% of Pseudomonas bacteraemias. There were no significant risk factors for acquiring a Pseudomonas isolate, and no difference in recurrent bacteraemia or infectious complication rates between the groups. CONCLUSIONS: In haemodialysis patients with a TCC-associated Pseudomonas bacteraemia, outcomes are remarkably good. This may be because the source of Pseudomonas infection was removed in most cases. Initial antibiotic coverage lacking anti-Pseudomonas activity was not associated with increased mortality.
Ladan Golestaneh; Jeffrey Laut; Stuart Rosenberg; Meilin Zhang; Michele H Mokrzycki
Related Documents :
11062197 - Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-d...
2049967 - Treatment of complicated urinary tract infections with ofloxacin following an aminoglyc...
25053527 - Preliminary report on a new hybrid metal stent for eus-guided biliary drainage (with vi...
3041817 - Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy fo...
22386067 - Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antip...
17032327 - Do supervised colorectal trainees differ from consultants in terms of quality of tme su...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2006-01-18
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  21     ISSN:  0931-0509     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-04-20     Completed Date:  2006-07-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  1328-33     Citation Subset:  IM    
Montefiore Medical Center, Department of Medicine, Division of Nephrology, Albert Einstein College of Medicine, Bronx, NY, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / therapeutic use
Bacteremia / drug therapy,  etiology*,  mortality
Catheters, Indwelling / adverse effects*
Cohort Studies
Equipment Contamination
Equipment Design
Equipment Safety
Follow-Up Studies
Kidney Failure, Chronic / diagnosis,  therapy
Middle Aged
Prospective Studies
Pseudomonas Infections / drug therapy,  etiology*,  mortality
Renal Dialysis / adverse effects*,  instrumentation*
Risk Assessment
Survival Rate
Treatment Outcome
Reg. No./Substance:
0/Anti-Bacterial Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Videolaparoscopy as rescue therapy and placement of peritoneal dialysis catheters: a thirty-two case...
Next Document:  Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and...